127 related articles for article (PubMed ID: 25761846)
41. Diffuse pontine glioma in Jordan and impact of up-front prognosis disclosure with parents and families.
Qaddoumi I; Ezam N; Swaidan M; Jaradat I; Mansour A; Abuirmeileh N; Bouffet E; Al-Hussaini M
J Child Neurol; 2009 Apr; 24(4):460-5. PubMed ID: 19074045
[TBL] [Abstract][Full Text] [Related]
42. Palliative and end-of-life care for children with diffuse intrinsic pontine glioma: results from a London cohort study and international survey.
Veldhuijzen van Zanten SE; van Meerwijk CL; Jansen MH; Twisk JW; Anderson AK; Coombes L; Breen M; Hargrave OJ; Hemsley J; Craig F; Cruz O; Kaspers GJ; van Vuurden DG; Hargrave DR;
Neuro Oncol; 2016 Apr; 18(4):582-8. PubMed ID: 26459800
[TBL] [Abstract][Full Text] [Related]
43. Can multiparametric MRI and FDG-PET predict outcome in diffuse brainstem glioma? A report from a prospective phase-II study.
Goda JS; Dutta D; Raut N; Juvekar SL; Purandare N; Rangarajan V; Arora B; Gupta T; Kurkure P; Jalali R
Pediatr Neurosurg; 2013; 49(5):274-81. PubMed ID: 25277867
[TBL] [Abstract][Full Text] [Related]
44. [The GLITRAD (Adult Brainstem Gliomas) network: A national multidisciplinary group dedicated to brainstem gliomas in adults].
Laigle-Donadey F; Loiseau H;
Bull Cancer; 2017 Jun; 104(6):593-595. PubMed ID: 28427714
[No Abstract] [Full Text] [Related]
45. Management of diffuse intrinsic pontine glioma in children: current and future strategies for improving prognosis.
Kaye EC; Baker JN; Broniscer A
CNS Oncol; 2014 Nov; 3(6):421-31. PubMed ID: 25438813
[TBL] [Abstract][Full Text] [Related]
46. School refusal and emotional lability in a 6-year-old boy.
Stein MT; Duffner PK; Werry JS; Trauner DA
J Dev Behav Pediatr; 2001 Apr; 22(2 Suppl):S29-32. PubMed ID: 11332806
[No Abstract] [Full Text] [Related]
47. Unforeseen Gifts: Seeking meaning while caring for children diagnosed with DIPG.
Schaefer MR
Pediatr Blood Cancer; 2024 Jan; 71(1):e30729. PubMed ID: 37856136
[No Abstract] [Full Text] [Related]
48. Brainstem Glioma: Clinical Profile and Challenges of Management in a Developing Country.
Oyemolade TA; Shokunbi MT; Badejo OA; Adeolu AA
West Afr J Med; 2019; 36(2):172-175. PubMed ID: 31385604
[TBL] [Abstract][Full Text] [Related]
49. Clinicopathology of diffuse intrinsic pontine glioma and its redefined genomic and epigenomic landscape.
Panditharatna E; Yaeger K; Kilburn LB; Packer RJ; Nazarian J
Cancer Genet; 2015; 208(7-8):367-73. PubMed ID: 26206682
[TBL] [Abstract][Full Text] [Related]
50. Children are not just little adults: recent advances in understanding of diffuse intrinsic pontine glioma biology.
Schroeder KM; Hoeman CM; Becher OJ
Pediatr Res; 2014 Jan; 75(1-2):205-9. PubMed ID: 24192697
[TBL] [Abstract][Full Text] [Related]
51. Treatment options in childhood pontine gliomas.
Wagner S; Warmuth-Metz M; Emser A; Gnekow AK; Sträter R; Rutkowski S; Jorch N; Schmid HJ; Berthold F; Graf N; Kortmann RD; Pietsch T; Sörensen N; Peters O; Wolff JE
J Neurooncol; 2006 Sep; 79(3):281-7. PubMed ID: 16598416
[TBL] [Abstract][Full Text] [Related]
52. A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study.
Macy ME; Kieran MW; Chi SN; Cohen KJ; MacDonald TJ; Smith AA; Etzl MM; Kuei MC; Donson AM; Gore L; DiRenzo J; Trippett TM; Ostrovnaya I; Narendran A; Foreman NK; Dunkel IJ
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28544128
[TBL] [Abstract][Full Text] [Related]
53. External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry.
Veldhuijzen van Zanten SEM; Lane A; Heymans MW; Baugh J; Chaney B; Hoffman LM; Doughman R; Jansen MHA; Sanchez E; Vandertop WP; Kaspers GJL; van Vuurden DG; Fouladi M; Jones BV; Leach J
J Neurooncol; 2017 Aug; 134(1):231-240. PubMed ID: 28560664
[TBL] [Abstract][Full Text] [Related]
54. Brainstem gliomas--retrospective analysis of 86 patients.
Ueoka DI; Nogueira J; Campos JC; Maranhão Filho P; Ferman S; Lima MA
J Neurol Sci; 2009 Jun; 281(1-2):20-3. PubMed ID: 19345380
[TBL] [Abstract][Full Text] [Related]
55. Conventional and Advanced Imaging of Diffuse Intrinsic Pontine Glioma.
Tisnado J; Young R; Peck KK; Haque S
J Child Neurol; 2016 Oct; 31(12):1386-93. PubMed ID: 27071471
[TBL] [Abstract][Full Text] [Related]
56. Radiation therapy and concurrent topotecan followed by maintenance triple anti-angiogenic therapy with thalidomide, etoposide, and celecoxib for pediatric diffuse intrinsic pontine glioma.
Porkholm M; Valanne L; Lönnqvist T; Holm S; Lannering B; Riikonen P; Wojcik D; Sehested A; Clausen N; Harila-Saari A; Schomerus E; Thorarinsdottir HK; Lähteenmäki P; Arola M; Thomassen H; Saarinen-Pihkala UM; Kivivuori SM
Pediatr Blood Cancer; 2014 Sep; 61(9):1603-9. PubMed ID: 24692119
[TBL] [Abstract][Full Text] [Related]
57. Tectal gliomas in children: the implications for natural history and management strategy.
Dağlioğlu E; Cataltepe O; Akalan N
Pediatr Neurosurg; 2003 May; 38(5):223-31. PubMed ID: 12686764
[TBL] [Abstract][Full Text] [Related]
58. Citrate concentrations increase with hypoperfusion in pediatric diffuse intrinsic pontine glioma.
Yeom KW; Lober RM; Nelson MD; Panigrahy A; Blüml S
J Neurooncol; 2015 Apr; 122(2):383-9. PubMed ID: 25670389
[TBL] [Abstract][Full Text] [Related]
59. Diffuse brain stem glioma.
Renard D; Le Floch A; Collombier L; De Verdal M; Campello C; Labauge P
Arch Neurol; 2010 Mar; 67(3):368-9. PubMed ID: 20212241
[No Abstract] [Full Text] [Related]
60. Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology.
Jansen MH; van Vuurden DG; Vandertop WP; Kaspers GJ
Cancer Treat Rev; 2012 Feb; 38(1):27-35. PubMed ID: 21764221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
